Amanda Freeman
Impact in
-
- Bone health and osteoporosis research
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
Papers in
-
- Pharmacogenetics and Drug Metabolism 5
- Antibiotics Pharmacokinetics and Efficacy 1
-
- Bone health and osteoporosis research 2
- Co-authors
- Sherry D. Holland (6 shared papers)Kenneth C. Lasseter (4 shared papers)Barry J. Gertz (4 shared papers)Arturo G. Porras (2 shared papers)Lawrence G. Raisz (1 shared paper)John C. Mucklow (1 shared paper)Carol Coke Pilbeam (1 shared paper)Scott G. Morham (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Clinical Investigation (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Amanda Freeman
11 papers receiving 704 citations
Peers
Comparison fields: 5 of 64
- Orthopedics and Sports Medicine 134
- Pharmacology 101
- Pharmaceutical Science 43
- Oncology 106
- Pharmacology 68
Countries citing papers authored by Amanda Freeman
This map shows the geographic impact of Amanda Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Freeman more than expected).
Fields of papers citing papers by Amanda Freeman
This network shows the impact of papers produced by Amanda Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Freeman. The network helps show where Amanda Freeman may publish in the future.
Co-authors
The 25 scholars most cited alongside Amanda Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 224 | |
| 2 | 2000 | 173 | |
| 3 | 2004 | 85 | |
| 4 | 1997 | 76 | |
| 5 | Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile. | 1997 | 75 |
| 6 | 1999 | 39 | |
| 7 | 1994 | 29 | |
| 8 | 1999 | 28 | |
| 9 | Drug interactions between caspofungin and tacrolimus | 2001 | 18 |
| 10 | 1999 | 14 | |
| 11 | 2011 | 12 |
About Amanda Freeman
Amanda Freeman is a scholar working on Pharmacology, Orthopedics and Sports Medicine, Pediatrics, Perinatology and Child Health, Infectious Diseases and Pharmaceutical Science, having authored 11 papers that have together received 773 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Bone health and osteoporosis research (2 papers), Antifungal resistance and susceptibility (2 papers), Pharmaceutical studies and practices (2 papers), Drug Solubulity and Delivery Systems (1 paper), Bone health and treatments (1 paper), Bone Metabolism and Diseases (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Orthopedics and Sports Medicine (134 citations), Pharmacology (101 citations), Pharmaceutical Science (43 citations), Oncology (106 citations) and Pharmacology (68 citations). Amanda Freeman has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Sherry D. Holland, Kenneth C. Lasseter, Barry J. Gertz, Arturo G. Porras, Lawrence G. Raisz, John C. Mucklow, Carol Coke Pilbeam, Scott G. Morham, Yosuke Okada and Masato Tomita. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Clinical Investigation, Clinical Pharmacology & Therapeutics and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.